The Trump administration integrates a federal office that funds the HIV test with another program, which raises scientists’ concerns about AIDS.Credit: Kevin Wurm/New York Times/Redux/Eyevine
The administration of US President Donald Trump has caught one of the federal offices aimed at ending the HIV in the country. The move comes at a time when the administration has reduced hundreds of grants that finance HIV and AIDS.
Changes are left with confusion: During the first Trump presidency, his administration launched a plan to eliminate HIV in the United States by 2030.
Late last week, many people in the American Office of Infectious Diseases and HIV/AIDS policy lost their jobs, according to a person in the US Department of Health and Humanitarian Services (HHS), the agency oversees the infectious Suritan infection office. This person asked not to reveal his identity because they were not cleared to speak to the media. Workers’ layoffs in the infectious addiction office have been confirmed by a second source familiar with the administration’s efforts to reduce HHS and restructure.
RFK JR vaccine is now a strong power in the United States Science: What will he do?
In addition, the US National Institutes of Health (NIH) has canceled more than 230 research research research and AIDS financing research in the past few weeks, according to nature Collective interbank analysis of the completed grants. CDC Centers (CDC) loses a major office to prevent HIV as part of restructuring.
All this adds to “devastating” discounts for research services and HIV in the United States, says Julia Marcos, an epidemic of infectious diseases at the Harvard University College of Medicine in Boston, Massachusetts, which has been completed by many scholarships. “The possible result will be a return to HIV.”
In response to questions from natureHHS issued a statement saying that the infectious addiction office does not close. Instead, HIV and AIDS virus are unified and simplified to avoid the presence of “multiple offices that do the same work through multiple sections.”
Sudden reflection
Workers’ demobilization is part of the Trump administration’s efforts to reduce the size of the federal government. HHS Robert F. Kennedy JR announced last week that his agency would lose 20,000 employees, or nearly a quarter of the workforce. Kennedy has repeatedly called on the federal government to focus more attention on chronic diseases and less on infectious diseases.
Request before nature On the administration’s commitment to the treatment of HIV and AIDS, a person familiar with the changes in HHS said that the remaining program “will continue to work very important to end HIV. This was a great priority for President Trump during the first administration.”
The HHS infection office was responsible for coordinating and supporting a policy called the United States HIV at the United States and HIV/AIDS minority. The office used approximately five scales, according to American media reports.
“I had tears in my eyes,” says Karl Schmid, who participated in the presidency of the Presidential Consultative Council on HIV/AIDS during the first Trump administration, when I hit the workers’ discharge. “These are the people who have devoted their lives to end HIV.”
Exclusively: NIH for Covid Research Grants, revealing documents
The HHS restructuring person said that the infectious removal office is combined with the HHS program that provides treatment for people with HIV/AIDS. The person said they do not know the number of people from the infectious infection office still have jobs. The person said that the CDC division is also combined to prevent HIV with this program.
But Adrian Shankar, who worked in health policy during the administration of former US President Joe Biden, says the merger is “a big problem.” The current HHS program focuses on treatment, while the division of the Disease Control Center focuses on prevention and the HHS infectious treatment office coordinates HIV monitoring throughout the country. Chanker says they cannot absorb each other’s responsibilities. “This will not make us closer to ending the epidemic,” he says.
Sarah Ziegler, who has worked for 20 years as a director of participation in the Center for Disease Control until May 2022, fears that the lack of experience in workers who assume other programs will lead to undermining HIV prevention efforts. “It is just an additional tragedy at the head of the tragedy,” says Ziegler. “This will harm people, will lead to the death of people and lead to a significant increase in all of our costs throughout the country.”